Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXI6ZN
|
||||
| Drug Name |
[1-(3-Methoxy-1-methyl-2-oxo-propylcarbamoyl)-3-methyl-butyl]-carbamic acid benzyl ester
|
||||
| Synonyms |
CHEMBL301683
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H28N2O5
|
||||
| Canonical SMILES |
COCC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1
|
||||
| InChI |
InChI=1S/C19H28N2O5/c1-13(2)10-16(18(23)20-14(3)17(22)12-25-4)21-19(24)26-11-15-8-6-5-7-9-15/h5-9,13-14,16H,10-12H2,1-4H3,(H,20,23)(H,21,24)/t14-,16-/m0/s1
|
||||
| InChIKey |
JOOITSNPEJONKV-HOCLYGCPSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.